BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 33270163)

  • 1. Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.
    Artymiuk CJ; Basu S; Koganti T; Tandale P; Balan J; Dina MA; Barr Fritcher EG; Wu X; Ashworth T; He R; Viswanatha DS
    J Mol Diagn; 2024 Jul; 26(7):583-598. PubMed ID: 38582399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted panel sequencing in the routine diagnosis of mature T- and NK-cell lymphomas: report of 128 cases from two German reference centers.
    Böck J; Maurus K; Gerhard-Hartmann E; Brändlein S; Kurz KS; Ott G; Anagnostopoulos I; Rosenwald A; Zamò A
    Front Oncol; 2023; 13():1231601. PubMed ID: 37664054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing in dermatology.
    King AD; Deirawan H; Klein PA; Dasgeb B; Dumur CI; Mehregan DR
    Front Med (Lausanne); 2023; 10():1218404. PubMed ID: 37841001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of HTS for Routine Plant Virus Diagnostics: State of the Art and Challenges.
    Maree HJ; Fox A; Al Rwahnih M; Boonham N; Candresse T
    Front Plant Sci; 2018; 9():1082. PubMed ID: 30210506
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigations of Pathologists as a Key to Understanding Coronavirus Disease 2019.
    Menter T; Tzankov A
    Pathobiology; 2021; 88(1):11-14. PubMed ID: 33341799
    [No Abstract]   [Full Text] [Related]  

  • 6. Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis.
    Schwotzer R; Flammer AJ; Gerull S; Pabst T; Arosio P; Averaimo M; Bacher VU; Bode P; Cavalli A; Concoluci A; Dirnhofer S; Djerbi N; Dobner SW; Fehr T; Garofalo M; Gaspert A; Heimgartner R; Hübers A; Jung HH; Kessler C; Knöpfel R; Laptseva N; Manka R; Mazzucchelli L; Meyer M; Mihaylova V; Monney P; Mylonas A; Nkoulou R; Pazhenkottil A; Pfister O; Rüfer A; Schmidt A; Seeger H; Stämpfli SF; Stirnimann G; Suter T; Théaudin M; Treglia G; Tzankov A; Vetter F; Zweier M; Gerber B
    Swiss Med Wkly; 2020 Nov; 150():w20364. PubMed ID: 33277911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications of next-generation sequencing in non-Hodgkin's lymphoma.
    Heimann P; Dewispelaere L
    Curr Opin Oncol; 2020 Sep; 32(5):391-397. PubMed ID: 32675596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Routine high-throughput targeted sequencing of lymphoproliferative diseases : Clinical utility and challenges].
    Menter T; Dirnhofer S; Tzankov A
    Pathologe; 2020 Dec; 41(Suppl 2):143-148. PubMed ID: 33270163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
    Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A
    BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
    Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
    Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience.
    Pillonel V; Juskevicius D; Bihl M; Stenner F; Halter JP; Dirnhofer S; Tzankov A
    Leuk Lymphoma; 2020 Nov; 61(11):2568-2583. PubMed ID: 32623938
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.